Skip to content

Clinical study on the treatment of recurrent oral ulcer and chronic pharyngitis with Compound Zhuye Shigao granule

Clinical study on the treatment of recurrent oral ulcer and chronic pharyngitis with Compound Zhuye Shigao granule

Status
Recruiting
Phases
Phase 2
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OIC-16008439
Enrollment
Unknown
Registered
2016-05-09
Start date
2016-05-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent oral ulcer and chronic pharyngitis

Interventions

treatment:drug
control:placebo

Sponsors

Department of traditional Chinese Medicine, Hainan branch of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. in line with ROU diagnostic criteria and research exclusion criteria; 2. course of diseases is more than one years; recurrent ulcer is more than one times per month and the ulcer attack is in 48 hours; 3. aged 18-60 years old, patients of independent behavior ability; 4. no other way to treat or take other drugs recently; 5. volunteers to accept treatment and to sign the relevant informed consent.

Exclusion criteria

Exclusion criteria: 1. suffering from heart, liver, kidney, hematopoietic system and the endocrine system and other serious primary disease such as mental illness; 2. Severe Behcet's syndrome,anemia, digestion ulcer, Crohn's disease, acute infectious diseases, autoimmune diseases, tumor and other systemic diseases history ; 3. Patients who use of analgesics within 24 hours , use of antibiotics and anti-inflammatory drugs after one month, use of corticosteroids, immunosuppressive agents within 3 months; 4. pregnant or lactating women or in the treatment period may be pregnant patients; 5. poor compliance, can not be successfully completed observation or incomplete information; 6. the researchers think that is not suitable to participate in clinical trials.

Design outcomes

Primary

MeasureTime frame
the scale of clinical symptom ;

Secondary

MeasureTime frame
blood and urine routine;Liver and kidney function;

Countries

China

Contacts

Public ContactLu Junzhang

General Hospital of PLA

lujunzhang@sina.com+86 136836668111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026